Krebs von den Lungen-6 (KL-6) as a diagnostic and prognostic biomarker for non-neoplastic lung diseases

What is it about?

Among innovative biomarkers investigated in order to evaluate the stage, response to treatment, and prognosis in patients with non-neoplastic lung diseases, Krebs von den Lungen-6 (KL-6) has been receiving growing attention. Mounting evidence now supports its usefulness and reliability in clinical practice.

Featured Image